Arrowstreet Capital’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
77,684
+46,379
+148% +$861K ﹤0.01% 1561
2026
Q1
$532K Sell
31,305
-17,771
-36% -$302K ﹤0.01% 1660
2025
Q4
$921K Hold
49,076
﹤0.01% 1571
2025
Q3
$627K Buy
49,076
+31,599
+181% +$474K ﹤0.01% 1673
2025
Q2
$294K Buy
+17,477
New +$236K ﹤0.01% 1836

Other funds holding NRC

Arrowstreet Capital's NRC Position: Q2 2026 in Review

Arrowstreet Capital increased its NRC Health Common Stock (NRC) stake by 148% in Q2 2026, buying an estimated $861K and bringing the position to 77,684 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1561.

Arrowstreet Capital first reported a position in NRC in Q2 2025 and has held it in 5 quarters since. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Arrowstreet Capital held 77,684 shares of NRC Health Common Stock worth $1.68M as of Q2 2026.
  • Arrowstreet Capital bought 46,379 NRC Health Common Stock shares in Q2 2026, an estimated $861K.
  • NRC Health Common Stock made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1561 holding.
  • Arrowstreet Capital first reported a position in NRC Health Common Stock in Q2 2025 and has held it in 5 quarters since.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.